Preventive effects of nano-graphene oxide against Parkinson’s disease via reactive oxygen species scavenging and anti-inflammation

키워드

참고문헌 (36)

1. Poewe W, "Parkinson disease", Nat Rev Dis Primers, 3, pp.1~21 (2017)
2. Fabbrini G, "Levodopa-induced dyskinesias", Mov Disord, 22, pp.1379~1389 (2007)
3. Benabid AL, "Deep brain stimulation for Parkinson’s disease", Curr Opin Neurobiol, 13, pp.696~706 (2003)
4. Kalia LV, "Disease-modifying strategies for Parkinson’s disease", Mov Disord, 30, pp.1442~1450 (2015)
5. Lotharius J, "Pathogenesis of Parkinson’s disease : dopamine, vesicles and alpha-synuclein", Nat Rev Neurosci, 3, pp.932~942 (2002)
6. Jenner P, "Oxidative stress in Parkinson’s disease", Ann Neurol, 53, pp.S26~S38 (2003)
7. Lee BC, "Graphene quantum dots as anti-inflammatory therapy for colitis", Sci Adv, 6, pp.eaaz2630~ (2020)
8. Han J, "Dual roles of graphene oxide to attenuate inflammation and elicit timely polarization of macrophage phenotypes for cardiac repair", Acs Nano, 12, pp.1959~1977 (2018)
9. Bacon M, "Graphene quantum dots", Part Part Syst Charact, 31, pp.415~428 (2014)
10. Kim D, "Graphene quantum dots prevent alpha-synucleinopathy in Parkinson’s disease", Nat Nanotechnol, 13, pp.812~818 (2018)
11. Jeong JK, "Autophagic flux induced by graphene oxide has a neuroprotective effect against human prion protein fragments", Int J Nanomedicine, 12, pp.8143~ (2017)
12. Xiaoli F, "Graphene oxide disrupted mitochondrial homeostasis through inducing intracellular redox deviation and autophagy-lysosomal network dysfunction in SH-SY5Y cells", J Hazard Mater, 416, pp.126158~ (2021)
13. Lee BC, "Graphene quantum dots as anti-inflammatory therapy for colitis", Sci Adv, 6, pp.eaaz2630~ (2020)
14. Ma J, "Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals", ACS Nano, 9, pp.10498~10515 (2015)
15. Yue H, "The role of the lateral dimension of graphene oxide in the regulation of cellular responses", Biomaterials, 33, pp.4013~4021 (2012)
16. Markovic ZM, "Graphene oxide size and structure pro-oxidant and antioxidant activity and photoinduced cytotoxicity relation on three cancer cell lines", J Photochem Photobiol B, 200, pp.111647~ (2019)
17. Guo S, "Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS–NO pathway", Free Radic Biol Med, 39, pp.682~695 (2005)
18. Shahriar SMS, "Graphene : a promising theranostic agent", Adv Exp Med Biol, 1351, pp.149~176 (2022)
19. Huang C, "Amphiphilic prodrug-decorated graphene oxide as a multifunctional drug delivery system for efficient cancer therapy", Mater Sci Eng C Mater Biol Appl, 89, pp.15~24 (2018)
20. Jiang W, "Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy", J Nanobiotechnology, 18, pp.50~ (2020)
21. Tabish TA, "Crossing the bloodbrain barrier with graphene nanostructures", Mater Today, 51, pp.393~401 (2021)
22. Mittal M, "Reactive oxygen species in inflammation and tissue injury", Antioxid Redox Signal, 20, pp.1126~1167 (2014)
23. Moore DJ, "Molecular pathophysiology of Parkinson’s disease", Annu Rev Neurosci, 28, pp.57~87 (2005)
24. Ren C, "Graphene oxide quantum dots reduce oxidative stress and inhibit neurotoxicity in vitro and in vivo through catalase-like activity and metabolic regulation", Adv Sci(Weinh), 5, pp.1700595~ (2018)
25. Srikanth K, "Graphene oxide induces cytotoxicity and oxidative stress in bluegill sunfish cells", J Appl Toxicol, 38, pp.504~513 (2018)
26. Nanda SS, "Oxidative stress and antibacterial properties of a graphene oxide-cystamine nanohybrid", Int J Nanomedicine, 10, pp.549~ (2015)
27. Wang A, "Role of surface charge and oxidative stress in cytotoxicity and genotoxicity of graphene oxide towards human lung fibroblast cells", J Appl Toxicol, 33, pp.1156~1164 (2013)
28. Elkon H, "Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells : implications for the pathogenesis of Parkinson’s disease", J Mol Neurosci, 24, pp.387~400 (2004)
29. Xicoy H, "The SH-SY5Y cell line in Parkinson’s disease research : a systematic review", Mol Neurodegener, 12, pp.10~ (2017)
30. Schober A, "Classic toxin-induced animal models of Parkinson’s disease : 6-OHDA and MPTP", Cell Tissue Res, 318, pp.215~224 (2004)
31. Olsson M, "Forelimb akinesia in the rat Parkinson model : differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test", J Neurosci, 15, pp.3863~3875 (1995)
32. Miyanishi K, "Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson’s disease model", Neurochem Int, 122, pp.38~46 (2019)
33. Mahmoudi M, "Graphene oxide strongly inhibits amyloid beta fibrillation", Nanoscale, 4, pp.7322~7325 (2012)
34. Ghaeidamini M, "Graphene oxide sheets and quantum dots inhibit alpha-synuclein amyloid formation by different mechanisms", Nanoscale, 12, pp.19450~19460 (2020)
35. Alimohammadi E, "Graphene-based nanoparticles as potential treatment options for Parkinson’s disease : a molecular dynamics study", Int J Nanomedicine, 15, pp.6887~6903 (2020)
36. Park WK, "Facile synthesis of graphene oxide in a Couette–Taylor flow reactor", Carbon, 83, pp.217~223 (2015)

관련 논문AI추천